Tempest Therapeutics, Inc. Annual Interest Expense in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Tempest Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2017 to 2023.
  • Tempest Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $372K, a 4.79% increase year-over-year.
  • Tempest Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $1.49M, a 1.97% decline year-over-year.
  • Tempest Therapeutics, Inc. annual Interest Expense for 2023 was $1.45M, a 10.4% decline from 2022.
  • Tempest Therapeutics, Inc. annual Interest Expense for 2022 was $1.62M, a 26.2% increase from 2021.
  • Tempest Therapeutics, Inc. annual Interest Expense for 2021 was $1.28M.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.45M -$169K -10.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $1.62M +$336K +26.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $1.28M +$1.28M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2018 $134K -$154K -53.5% Jan 1, 2018 Dec 31, 2018 10-K 2019-04-01
2017 $288K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.